GBC Blog

Curetis and Acumen to Collaborate on Unyvero Sepsis Test and ASEAN Distribution Curetis licenses Acumen’s proprietary sepsis biomarker panel for use with Unyvero Platform Diagnostics Development (DxD) Hub in Singapore to support Acumen in development and clinical validation of the panel Acumen to distribute Unyvero product line in ASEAN countries [LINK] Holzgerlingen, Germany and Singapore,…

Curetis Unyvero (Video):  In vitro diagnostic for rapid pathogen and antibiotic resistance profiling. Select link below to view video : https://www.youtube.com/watch?v=khQETD4qZio

Curetis Enters into Distribution Agreement to Expand Commercial Activities into Greater China Exclusive Unyvero distribution agreement with Beijing Clear Biotech Co., Ltd. for Mainland China, Hong Kong and Taiwan Clinical trials for CFDA regulatory approval in preparation [Link] Holzgerlingen, Germany, September 25, 2015 — Curetis AG, a developer of next-level molecular diagnostic solutions, today announced…

Select link below to view article: http://www.theguardian.com/science/2015/may/07/personalised-cancer-treatment-a-step-closer-with-worlds-first-living-biobank

Epigenomics and BioChain Announce Inclusion of Septin9 Test in Chinese Screening Guideline Epigenomics AG : Epigenomics and BioChain announce the inclusion of their proprietary blood-based Septin9 test in the Chinese screening guideline for colorectal cancer. Source text for Eikon: Further company coverage: (Gdynia Newsroom) Select link below to view brief: http://www.reuters.com/article/2015/07/15/idUSFWN0ZV02220150715 Epigenomics, BioChain Announce Inclusion…

Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections First patient enrolled in prospective arm of IVD trial  Study to include a total of at least 2,500 patient samples Milestone triggers payment of EUR 6.8 million financing tranche [Link] Holzgerlingen, Germany, July 8, 2015 — Curetis AG, a developer of…

Select link below to view press release: http://akampioneer.com/company-news/company-news-curetis%E2%80%99-unyvero-system-selected-for-global-phase-iii-antibiotics-trial.html  

Select link below to view CAP article: http://www.captodayonline.com/maldi-microbiology-set-stun/

Select link below to view press release: Reuters: http://www.reuters.com/article/2015/05/08/epigenomics-brief-idUSWEA00GZB20150508 Epigenomics: http://www.epigenomics.com/en/news-investors/news-media/ad-hoc-releases/article/ad-hoc-epigenomics-epi-procolonR-erreicht-in-admit-studie-eine-teilnehmerrate-von-995.html

Select link below to view press release: Epigenomics Wins $3.1M Grant to Validate Lung Cancer Biomarkers